Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v7-FR
Language French French
Date Updated 2019-04-17 2019-04-11
Drug Identification Number 02230769 02230769
Brand name DALMACOL DALMACOL
Common or Proper name Dalmacol Dalmacol
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients DOXYLAMINE SUCCINATE SODIUM CITRATE HYDROCODONE BITARTRATE ALCOHOL ANHYDROUS ETAFEDRIN HYDROCHLORIDE DOXYLAMINE SUCCINATE SODIUM CITRATE HYDROCODONE BITARTRATE ALCOHOL ANHYDROUS ETAFEDRIN HYDROCHLORIDE
Strength(s) 1.2MG 40MG .33MG .05ML 3.33MG 1.2MG 40MG .33MG .05ML 3.33MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 2L 2L
ATC code R05DA R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-08-22 2018-08-22
Actual start date 2018-08-22 2018-08-22
Estimated end date 2018-12-01 2018-12-01
Actual end date 2018-12-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments